Akero Therapeutics Net Income
| AKRODelisted Stock | USD 54.65 0.00 0.00% |
As of the 16th of February 2026, Akero Therapeutics shows the risk adjusted performance of 0.113, and Mean Deviation of 1.14. Akero Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Akero Therapeutics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Akero Therapeutics' valuation are provided below:Akero Therapeutics does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Akero |
Search Suggestions
| AK | AK | ETF |
| AKA | AKA Brands Holding | Company |
| AKGCX | Ab Income Fund | Mutual Fund |
| AKT | Akash Network | Cryptocurrency |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Akero Therapeutics reported net income of (252.06 Million). This is 173.86% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 144.15% higher than that of the company.
Akero Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Akero Therapeutics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Akero Therapeutics could also be used in its relative valuation, which is a method of valuing Akero Therapeutics by comparing valuation metrics of similar companies.Akero Therapeutics is currently under evaluation in net income category among its peers.
Akero Fundamentals
| Return On Equity | -0.35 | |||
| Return On Asset | -0.23 | |||
| Current Valuation | 3.76 B | |||
| Shares Outstanding | 82.32 M | |||
| Shares Owned By Insiders | 1.45 % | |||
| Shares Owned By Institutions | 98.55 % | |||
| Number Of Shares Shorted | 4.32 M | |||
| Price To Earning | (7.43) X | |||
| Price To Book | 4.70 X | |||
| EBITDA | (247.37 M) | |||
| Net Income | (252.06 M) | |||
| Cash And Equivalents | 180.72 M | |||
| Cash Per Share | 4.81 X | |||
| Total Debt | 36.46 M | |||
| Debt To Equity | 0.07 % | |||
| Current Ratio | 6.90 X | |||
| Book Value Per Share | 11.95 X | |||
| Cash Flow From Operations | (230.11 M) | |||
| Short Ratio | 2.33 X | |||
| Earnings Per Share | (3.75) X | |||
| Price To Earnings To Growth | 0.93 X | |||
| Target Price | 56.5 | |||
| Number Of Employees | 74 | |||
| Beta | -0.4 | |||
| Market Capitalization | 4.5 B | |||
| Total Asset | 825.89 M | |||
| Retained Earnings | (826.16 M) | |||
| Working Capital | 730.63 M | |||
| Current Asset | 22.85 M | |||
| Current Liabilities | 859.05 K | |||
| Net Asset | 825.89 M |
About Akero Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Akero Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Akero Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Akero Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Akero Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Akero Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akero Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Akero Stock
| 0.93 | NIVF | NewGenIvf Group | PairCorr |
| 0.87 | TRNR | Interactive Strength | PairCorr |
| 0.86 | APVO | Aptevo Therapeutics | PairCorr |
| 0.58 | AFIIQ | Armstrong Flooring | PairCorr |
| 0.42 | BRK-A | Berkshire Hathaway Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Akero Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Akero Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Akero Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Akero Therapeutics to buy it.
The correlation of Akero Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Akero Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Akero Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Akero Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Consideration for investing in Akero Stock
If you are still planning to invest in Akero Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Akero Therapeutics' history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |